Skip to content
ClinCalc Pro
Menu
Tetracycline antibiotic

Minocycline

Brand names: Aknemin, Minocin

Minocycline is a tetracycline antibacterial used for acne and a range of other susceptible infections, valued for its broad activity and good tissue penetration.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It binds reversibly to the bacterial 30S ribosomal subunit, blocking attachment of aminoacyl-tRNA to the ribosome and inhibiting protein synthesis.

Prescribing in practice

  • Unlike other tetracyclines it can rarely cause hypersensitivity syndromes, lupus-like reactions, hepatitis and irreversible skin, mucosal or scleral pigmentation, so treatment should be reviewed and stopped if these occur.
  • It is contraindicated in pregnancy, breastfeeding and in children because tetracyclines deposit in growing bone and teeth, causing discolouration.
  • Absorption is reduced by antacids and iron, zinc, calcium or magnesium-containing products, which should be separated from the dose.

Monitoring

Review periodically for hepatic, autoimmune and pigmentation effects, and reassess the need for continued treatment in long-term acne use.

Counselling the patient

  • Report joint pain, rash, fever or any new skin or gum discolouration.
  • Avoid taking with milk, indigestion remedies or iron and mineral supplements at the same time.
  • Take with plenty of water and do not lie down immediately afterwards to avoid throat irritation.

Evidence & guidelines

Prescribing reflects the SPC and MHRA advice on the risks of pigmentation and hypersensitivity reactions with minocycline.

Reference: NICE NG198 acne; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.